Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN65,6665,8-0,41
Msft0,92
Nokia3,3613,49950,88
IBM-0,84
Mercedes-Benz Group AG63,8163,83-1,06
PFE0,00
22.06.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 21.06.2024 21:59:36
Danaher Corp (DHR, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
255,00 2,59 6,43 3 921 955
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 22.06.2024
Popis společnosti
Obecné informace
Název společnostiDanaher Corp
TickerDHR
Kmenové akcie:Ordinary Shares
RICDHR
ISIN-
Prioritní akciePreferred Shares Series A
RICDHR_pa.N^D22
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky29.03.2024
Počet zaměstnanců k 31.12.2023 61 000
Akcie v oběhu k 18.04.2024 740 686 541
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice2200 Pennsylvania Ave NW Ste 800W
MěstoWASHINGTON
PSČ20037-1731
ZeměUnited States
Kontatní osobaJohn Bedford
Funkce kontaktní osobyVice President - Investor Relations
Telefon12 028 280 850
Fax12028280860
Kontatní telefon12 028 280 850

Business Summary: Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Financial Summary: BRIEF: For the three months ended 29 March 2024, Danaher Corp revenues decreased 3% to $5.8B. Net income applicable to common stockholders excluding extraordinary items decreased 11% to $1.09B. Revenues reflect Biotechnology segment decrease of 18% to $1.52B. Net income also reflects Biotechnology segment income decrease of 45% to $325M, Life Sciences segment income decrease of 27% to $235M, Other segment loss increase of 1% to $78M.
Odvětvová klasifikace
TRBC2009Industrial Machinery / Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Industrial Machinery & Equipment
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICSInstruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
NAICSCommercial and Service Industry Machinery Manufacturing
NAICSPetroleum and Petroleum Products Merchant Wholesalers (except Bulk Stations and Terminals)
NAICSTesting Laboratories and Services
NAICSInstrument Manufacturing for Measuring and Testing Electricity and Electrical Signals
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSAll Other Business Support Services
NAICS2007Industrial Process Control Mfg
NAICS2007Oth Commercial/Service Industry Machinery Mfg
NAICS2007Petroleum and Petroleum Products Merchant Wholesalers (except Bulk Stations and Terminals)
NAICS2007Testing Laboratories
NAICS2007Electricity Measuring/Testing Instrument Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS2007All Other Business Support Services
NAICS2007Hand & Edge Tool Mfg
NAICS1997Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
NAICS1997Other Commercial and Service Industry Machinery Manufacturing
NAICS1997Petroleum and Petroleum Products (except Bulk Stations and Terminals) Wholesalers
NAICS1997Testing Laboratories
NAICS1997Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997All Other Business Support Services
NAICS1997Hand and Edge Tool Manufacturing
SICProcess Control Instruments
SICProcess Control Instruments
SICService Industry MacHinery, Nec
SICPetroleum Products, Nec
SICTesting Laboratories
SICInstruments To Measure Electric
SICElectromedical Equipment
SICBusiness Services, Nec



  • Poslední aktualizace: 22.06.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardSteven Rales72
President, Chief Executive Officer, DirectorRainer Blair5901.09.2020
Chief Financial Officer, Executive Vice PresidentMatthew McGrew5201.01.201901.01.2019
Executive Vice PresidentChristopher Riley5001.01.202401.01.2024
Executive Vice President - DiagnosticsJulie Sawyer Montgomery-01.07.202401.07.2024
Executive Vice President - DiagnosticsJoakim Weidemanis54
Senior Vice President, Chief Science OfficerJose-Carlos Gutierrez-Ramos6121.12.202021.12.2020
Senior Vice President, General CounselBrian Ellis58
Senior Vice President - Human ResourcesGeorgeann Couchara4701.04.202201.04.2022
Senior Vice President - Strategic DevelopmentWilliam King56